<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref ref-type="fig" rid="molecules-26-00137-f004">Figure 4</xref> shows the effects of various treatments on lipid profiles of diabetic rats on day 21. Rats in the diabetic control group (group II) showed significant (
 <italic>p</italic> &lt; 0.001) increases in plasma lipid parameters TC, TG, LDL, and HbA1c, however a significant (
 <italic>p</italic> &lt; 0.001) decrease in plasma HDL compared to normal saline control rats (groups I) was observed. Standard glibenclamide (5 mg/kg) has significantly decreased (
 <italic>p</italic> &lt; 0.001) the plasma TC, TG, and LDL levels in diabetic rats. However, oral administration of CTN (15, 30, and 50 mg/kg, respectively) has significantly decreased (
 <italic>p</italic> &lt; 0.001) TC, TG, and LDL levels, while significantly increased (
 <italic>p</italic> &lt; 0.001) HDL cholesterol in diabetic rats was also observed as compared to diabetic control rats.
</p>
